MELANIE MEAD: Open Payments
NPI 1942257266 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$311 in 11 payments from 9 companies in 2025. Trend: 2023 $568 · 2024 $453 · 2025 $311
Food & beverage: $311
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 2 | $124 |
| Organon LLC | 2 | $50 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Hologic Sales and Service, LLC | 1 | $21 |
| Sage Therapeutics, LLC | 1 | $21 |
| Exeltis, USA Inc. | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| MILLICENT US INC | 1 | $17 |
| Astellas Pharma US Inc | 1 | $15 |
Products named: BIJUVA, NEXPLANON, MYFEMBREE, ACESSA PROVU SYSTEM, ZURZUVAE, SLYND, Lynkuet, FEMRING.
Industry payments across OK — which companies pay providers there.
